Delayed
Deutsche Boerse AG
12:59:59 29/07/2023 am IST
|
5-day change
|
1st Jan Change
|
0.006
EUR
|
-40.00%
|
|
-.--%
|
-.--%
|
Fiscal Period: December |
2021
|
2022
|
---|
Capitalization
1 |
15.84
|
3.873
|
Enterprise Value (EV)
1 |
16.14
|
9.747
|
P/E ratio
|
-1.05
x
|
-0.46
x
|
Yield
|
-
|
-
|
Capitalization / Revenue
|
14,53,459
x
|
3,82,516
x
|
EV / Revenue
|
14,81,237
x
|
9,62,806
x
|
EV / EBITDA
|
-26,04,140
x
|
-14,57,350
x
|
EV / FCF
|
-47,82,754
x
|
-39,27,447
x
|
FCF Yield
|
-0%
|
-0%
|
Price to Book
|
3.67
x
|
-1.1
x
|
Nbr of stocks (in thousands)
|
93,409
|
93,722
|
Reference price
2 |
0.1695
|
0.0413
|
Announcement Date
|
26/04/22
|
25/04/23
|
Fiscal Period: December |
2020
|
2021
|
2022
|
---|
Net sales
|
-
|
10.9
|
10.12
|
EBITDA
|
-
|
-6.197
|
-6.688
|
EBIT
1 |
-1.498
|
-6.453
|
-6.976
|
Operating Margin
|
-
|
-59.23%
|
-68.91%
|
Earnings before Tax (EBT)
1 |
-1.498
|
-8.892
|
-8.351
|
Net income
1 |
-1.498
|
-8.866
|
-8.351
|
Net margin
|
-
|
-81.38%
|
-82.49%
|
EPS
|
-
|
-0.1612
|
-0.0891
|
Free Cash Flow
|
-
|
-3.374
|
-2.482
|
FCF margin
|
-
|
-30.97%
|
-24.51%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
Announcement Date
|
31/05/21
|
26/04/22
|
25/04/23
|
Fiscal Period: December |
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
0.3
|
5.87
|
Net Cash position
1 |
0
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-0.0488
x
|
-0.8784
x
|
Free Cash Flow
|
-
|
-3.37
|
-2.48
|
ROE (net income / shareholders' equity)
|
-
|
-450%
|
-2,076%
|
ROA (Net income/ Total Assets)
|
-
|
-90.9%
|
-62.9%
|
Assets
1 |
-
|
9.753
|
13.29
|
Book Value Per Share
|
-
|
0.0500
|
-0.0400
|
Cash Flow per Share
|
-
|
0.0300
|
0
|
Capex
|
-
|
0.1
|
0
|
Capex / Sales
|
-
|
0.91%
|
0.04%
|
Announcement Date
|
31/05/21
|
26/04/22
|
25/04/23
|
|
1st Jan change
|
Capi.
|
---|
| -.--% | 605K | | +22.07% | 88.99B | | -24.09% | 74.82B | | +1.06% | 26.63B | | +3.92% | 17.88B | | -13.32% | 16.43B | | +2.56% | 15.77B | | +77.53% | 13.21B | | +70.91% | 13.08B | | +39.76% | 12.9B |
Other Healthcare Facilities & Services
|